| Document |
Document Title |
|
WO/2013/136029A1 |
The invention relates to new strains of cyanobacteria belonging to the Nostoc genus, allowing high-yield production of polysaccharides, in mixotrophic mode, and to a method for selecting and culturing such strains, using a variable and/o...
|
|
WO/2013/136025A1 |
The invention relates to new strains of microalgae belonging to the Nitzschia genus, allowing high-yield production of lipids, in particular of docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA) and/or carotenoids, in particul...
|
|
WO/2013/136028A1 |
The invention relates to new strains of protists belonging to the Schizochytrium genus, allowing high-yield production of lipids and carotenoids, in particular of astaxanthin and docosahexaenoic acid (DHA), in mixotrophic mode, and to a ...
|
|
WO/2013/136026A1 |
The invention relates to a method for enriching new strains of microalgae belonging to the Botryococcus genus with capric acid, under mixotrophic culture conditions and in the presence of an organic carbonaceous substrate. The biomass an...
|
|
WO/2013/136024A1 |
The invention relates to novel strains of microalgae belonging to the Cyclotella cryptica species and enabling the high-yield production of lipids, in particular eicosapentaenoic acid (EPA) and/or docosahexaenoic acid (DHA), in mixotroph...
|
|
WO/2013/136023A1 |
The invention relates to new strains of microalgae belonging to the Euglena genus, allowing production of lipids, in particular of EPA and/or ARA, in mixotrophic mode, and to a method for selecting and culturing such strains, using a var...
|
|
WO/2013/133485A1 |
Disclosed are an ultrasonic Petri dish used for experimenting on the reaction of a cell to ultrasonic waves or applying ultrasonic waves to a cell, and an ultrasonic monitoring system using same. The ultrasonic Petri dish is characterize...
|
|
WO/2013/120206A1 |
A method for producing hydrogen from organic material. Organic material and hydrogen-producing microorganisms are provided in a completely mixed bioreactor for breaking down the organic material into H2, CO2, fatty acids,and alcohols. H2...
|
|
WO/2013/119511A1 |
The present disclosure provides devices, systems, and methods for affecting cells using low voltage high electric fields (LVHEF). In one embodiment, the present disclosure provides for reduction of microbial contamination using low volta...
|
|
WO/2013/111923A1 |
The present invention relates to a method for detecting the repair gene of cancer onset regulating DNA in mice irradiated with ionizing radiation and to a DNA repair gene group, wherein the method comprises: a) preparing a number of AKR/...
|
|
WO/2013/092967A1 |
The present invention relates to novel bacteria and the uses thereof. The invention particularly relates to bacteria having a metabolic pathway ratio between Pentose phosphate and glycolysis greater than 0.5, and their uses in the chemic...
|
|
WO/2013/078270A1 |
Methods and devices are described for the regulation of BMP 2 and 4, TGF-beta 1, 2, and 3, FGF-2, osteocalcin, and alkaline phosphatase mRNA in stem cells via capacitive coupling or inductive coupling of specific and selective electric a...
|
|
WO/2013/075131A1 |
Systems, devices, and methods for delivering a biological material into an organelle of a cell are provided. In one aspect, for example, a method for introducing biological material into an organelle of a cell can include bringing into p...
|
|
WO/2013/058537A2 |
|
|
WO/2013/040688A1 |
The present document describes a method of increasing expression of a recombinant protein of an isolated eukaryotic cell comprising a recombinant DNA, by exposing the isolated eukaryotic cell to ultrasound having a frequency from greater...
|
|
WO/2013/032938A1 |
Disclosed herein, are methods of preparing sterilized amniotic tissues. Further disclosed herein, are methods of using the sterilized amniotic tissues.
|
|
WO/2013/030376A1 |
The present invention relates to a process for the electrochemical reduction of CO2 catalysed by an electrochemically active biofilm, in the presence of a metal cathode and Geobacter sulfurreducens.
|
|
WO/2013/027053A2 |
The present invention relates to the use of microwave energy to enhance the activity of enzymatic reactions, such as enhancing the activity of enzymes involved in the degradation of cellulose to glucose and intermediates thereto. The inv...
|
|
WO/2013/024918A1 |
The present invention relates to gene groups serving as observation indexes for cancer progression, and to a method for detecting the gene groups, which are indicators for observing cancer proliferation or regression when radiation is ra...
|
|
WO/2013/021138A2 |
The invention relates to yeast flakes enriched with vitamin D2, to compositions including said flakes, and to the uses thereof, as well as to a method for preparing yeast flakes enriched with vitamin D2 and to the device for implementing...
|
|
WO/2013/013304A1 |
Devices and methods are provided for electrically lysing cells and releasing macromolecules from the cells. A microfluidic device is provided that includes a planar channel having a thickness on a submillimeter scale, and including elect...
|
|
WO/2013/012452A2 |
Disclosed herein are methods and systems for controlled ejection of desired material onto surfaces including single cells using nanopipettes, as well as ejection and into cells. Some systems are directed to a method and system comprising...
|
|
WO/2013/010257A1 |
An apparatus (20) for dehydrating organic material in batches has a processing unit (22) having a microwave-vacuum chamber (34), an input module (28) and an output module (30), with a conveyor (54) for moving the material through the cha...
|
|
WO/2012/177778A1 |
The present invention relates to methods of treating a subject with a lysosomal disorder, by administering an agent for enzyme replacement therapy and an agent for anti-TNF-α therapy; by administering a pentosan polysulfate therapy; or ...
|
|
WO/2012/175027A1 |
A new Schizochytrium variant strain is provided. In particular, a new Schizochytrium variant strain having properties of increased DHA content and/or improved growth rate, and a method for producing DHA with the same are provided. Also p...
|
|
WO/2012/170909A1 |
The present invention provides a method for non-invasive acoustic stimulation of stem cells and/or progenitor cells in a patient. The invention also provides a device for non-invasive stimulation of stem cells and/or progenitor cells in ...
|
|
WO/2012/162049A2 |
The present disclosure provides a method for assessing exposure to ionizing radiation comprising the steps of (a) measuring the RNA expression level of certain biomarker genes in a biological sample; (b) correcting the RNA expression lev...
|
|
WO/2012/162546A2 |
Systems, devices, and methods for delivering a biological material into a cell are provided. In one example, a lance device for introducing biological material into a cell and configured for use in a nanoinjection system including a micr...
|
|
WO/2012/162133A1 |
The present invention features methods for selective lysis of endogenous cells in a biological sample. In preferred embodiments, the methods of the invention comprise contacting the biological sample with lysis solution, and subjecting t...
|
|
WO/2012/149166A1 |
Systems, devices, and methods for delivering a biological material into an organelle of a cell are provided. In one aspect, for example, a method for introducing biological material into an organelle of a cell includes bringing into prox...
|
|
WO/2012/148584A1 |
Provided herein are improved cell sorter systems and methods. Such systems and methods provide a self-stabilizing sorter jet to automate calibration, and address the issue of drift in cell sorting systems. The systems and methods present...
|
|
WO/2012/145018A1 |
Compositions that include sets of magnetic particles, where the members of each set of particles are conjugated to an antibody specific for a pathogen, are provided.
|
|
WO/2012/145019A1 |
Provided are methods of using compositions that include sets of magnetic particles, members of each set being conjugated to an antibody specific for a pathogen, and magnets to isolate a pathogen from a body fluid sample.
|
|
WO/2012/141454A2 |
The present invention relates to a graft material derived from mammalian cartilage. The graft material according to the present invention has significantly lowered risk by eliminating antigenicity, pathogen and cytotoxicity through multi...
|
|
WO/2012/138741A2 |
A device, system and method for treating biological cells includes a voltage source, a half-controlled bridge connected to the voltage source, and a load connected across the half-controlled bridge. The half- controlled bridge includes a...
|
|
WO/2012/131008A2 |
The present invention relates to inactivation of bacteriophages in a liquid, such as bacterial growth medium, milk and whey.
|
|
WO/2012/135838A1 |
Methods for purifying very small embryonic-like (VSEL) stem cells from populations of cells suspected of including VSEL stem cells are provided. In some embodiments, the methods include (a) providing a population of cells suspected of in...
|
|
WO/2012/133804A1 |
The purpose of the invention is to provide a cell modification method with which a property of cells can be modified. The cell modification method of the invention involves exposing cells to an electrical field generated by pulsed voltag...
|
|
WO/2012/129031A2 |
A method is described by which a growth medium is exposed to an electric field of sufficient magnitude to kill competing microorganisms and insufficient magnitude to cause flocculation to an algae population.
|
|
WO/2012/129360A2 |
Methods for isolating viable cancer cells from a sample that comprises a mixture of cancerous cells and normal (non-cancerous) cells are provided. In the methods, a fluid preparation comprising a mixture of cancerous and normal cells is ...
|
|
WO/2012/126187A1 |
A rhizopus oryzae strain, mutagenesis and screening methods thereof, and methods of producing fumaric acid by fermentation are provided. The said stain is named as Rhizopus oryzae ME-F13, and has been deposited in China Center for Type C...
|
|
WO/2012/122564A2 |
Contemplated methods and devices are drawn to preparation and analysis of analytes from biological samples. In a preferred embodiment the analytes are nucleic acids that are both released from biological compartments present in the sampl...
|
|
WO/2012/118857A2 |
A method for constructing a compound of immunologically modified nanotubes and method for using the compound to deliver immunoadjuvants to tumor cells and to produce targeted, synergistic photophysical and immunological reactions for can...
|
|
WO/2012/106796A1 |
A process of growing a phototrophic biomass in a reaction zone, including a reaction mixture that is operative for effecting photosynthesis upon exposure to photosynthetically active light radiation, is provided. The reaction mixture inc...
|
|
WO/2012/103227A1 |
A method of disinfecting a biological material provides disposing at least a portion of the biological material in the path of the gas cluster ion beam or in the path of the accelerated neutral beam so as to irradiate at least a portion ...
|
|
WO/2012/101459A2 |
The present invention relates to processes for the production of microalgae, cyanobacteria and/or metabolites thereof. Described herein is a process involving the use of a stimulus applied to a microalgal or cyanobacterial culture to enh...
|
|
WO/2012/097413A1 |
The present disclosure teaches the facilitation of fluid mixing in microliter volume environments. Enabled herein is enhanced mixing of molecular and cellular participants in a biochemical, chemical or physiological transformation within...
|
|
WO/2012/100194A1 |
Methods and apparatus for fragmenting nucleic acids or disrupting cells in a disposable microfluidic device are disclosed. The apparatus is designed to position a sample to be in direct contact with a high frequency vibrating element tha...
|
|
WO/2012/053718A9 |
The present invention relates to a method for differentiation of mesenchymal stem cells or dental pulp stem cells. More specifically, the invention relates to a method for differentiating stem cells to nerve cells by processing mesenchym...
|
|
WO/2012/091911A1 |
Methods of treating using adipose tissue using ultrasonic cavitation to dissociate the fat cells and blood vessels contained within adipose tissue and thereby obtain mesenchymal or stromal vascular fractions for use in human subjects are...
|
